Cite

    Kalliopi Pafili et al.. “Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?.” Expert opinion on pharmacotherapy, vol. 19, 2018, pp. 185–187. http://access.bl.uk/ark:/81055/vdc_100056633697.0x00003c